- About Us
- Nano-Social Network
- Nano Consulting
- My Account
December 31st, 2006
Ahmedabad-based pharma major Dishman Pharmaceuticals and Chemicals (DPCL) is keen to acquire biotech and nanotechnology contract research organisation (CRO) companies in the US and Europe.
Talking to Business Standard, J R Vyas, MD of Dishman Pharma, said, "We are keen to acquire CROs companies operating in biotech and nanotechnolgy research."
|Related News Press|
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Argon is not the 'dope' for metallic hydrogen March 24th, 2017
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016